Antimicrobial drug resistance of Salmonella enterica serovar typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolones.
about
Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever)Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella InfectionsSystematic review of the global epidemiology, clinical and laboratory profile of enteric feverA multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in VietnamThe sudden dominance of blaCTX-M harbouring plasmids in Shigella spp. Circulating in Southern VietnamA randomised trial evaluating the safety and immunogenicity of the novel single oral dose typhoid vaccine M01ZH09 in healthy Vietnamese childrenTemporal fluctuation of multidrug resistant salmonella typhi haplotypes in the mekong river delta region of VietnamEmergence of a globally dominant IncHI1 plasmid type associated with multiple drug resistant typhoidAzithromycin and ciprofloxacin resistance in Salmonella bloodstream infections in Cambodian adultsIdentification of Salmonella enterica serovar Typhi genotypes by use of rapid multiplex ligation-dependent probe amplificationA safe vaccine (DV-STM-07) against Salmonella infection prevents abortion and confers protective immunity to the pregnant and new born miceHigh-throughput bacterial SNP typing identifies distinct clusters of Salmonella Typhi causing typhoid in Nepalese children.Genetic diversity of Salmonella enteric serovar typhi and paratyphi in Shenzhen, China from 2002 through 2007Searching for the elusive typhoid diagnosticCommercializing diarrhea vaccines for travelers.Taming the elephant: Salmonella biology, pathogenesis, and prevention.The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections.The influence of reduced susceptibility to fluoroquinolones in Salmonella enterica serovar Typhi on the clinical response to ofloxacin therapyAntibiotic use and resistance in emerging economies: a situation analysis for Viet Nam.A multi-center randomized trial to assess the efficacy of gatifloxacin versus ciprofloxacin for the treatment of shigellosis in Vietnamese childrenHigh-resolution genotyping of the endemic Salmonella Typhi population during a Vi (typhoid) vaccination trial in Kolkata.Suitable disk antimicrobial susceptibility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluoroquinolonesDoes HIV status affect the aetiology, bacterial resistance patterns and recommended empiric antibiotic treatment in adult patients with bloodstream infection in Cambodia?Antimicrobial resistance in Salmonella enterica Serovar Typhi isolates from Bangladesh, Indonesia, Taiwan, and Vietnam.Typhoid fever in Fiji: a reversible plague?Gatifloxacin versus ofloxacin for the treatment of uncomplicated enteric fever in Nepal: an open-label, randomized, controlled trialClinically and microbiologically derived azithromycin susceptibility breakpoints for Salmonella enterica serovars Typhi and Paratyphi AA novel technique for detecting antibiotic-resistant typhoid from rapid diagnostic tests.Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events.Emergence of Ciprofloxacin-Resistant Salmonella enterica Serovar Typhi in ItalyWhole Genome Sequence Analysis of Salmonella Typhi Isolated in Thailand before and after the Introduction of a National Immunization Program.The impact of migration and antimicrobial resistance on the transmission dynamics of typhoid fever in Kathmandu, Nepal: A mathematical modelling studyClinical implications of reduced susceptibility to fluoroquinolones in paediatric Shigella sonnei and Shigella flexneri infectionsA comparative study of efficacy and safety of azithromycin and ofloxacin in uncomplicated typhoid Fever: a randomised, open labelled studyA Multicountry Molecular Analysis of Salmonella enterica Serovar Typhi With Reduced Susceptibility to Ciprofloxacin in Sub-Saharan Africa.The emergence and outbreak of multidrug-resistant typhoid fever in China.High-throughput sequencing provides insights into genome variation and evolution in Salmonella TyphiReduced fluoroquinolone susceptibility in Salmonella enterica isolates from travelers, Finland.Fitness benefits in fluoroquinolone-resistant Salmonella Typhi in the absence of antimicrobial pressure.Characterization of non-classical quinolone resistance in Salmonella enterica serovar Typhi: Report of a novel mutation in gyrB gene and diagnostic challenges
P2860
Q24241438-31F55C9E-4685-4F80-94FA-CC6CD79AF0B3Q28084595-7006D75A-FB69-4FA7-B385-F37B615C4DD0Q28085053-F32BFD79-7B69-4603-B54A-E84E34568288Q28472731-503A2105-938C-4DA8-B15F-24EF6EED3AD9Q28474307-565F9424-6231-476B-82D9-FA3953FC499EQ28474905-858A37AB-D222-48B8-BC27-C2A68099A042Q28476687-F3F399BC-BA35-437A-BC06-98BD1614C633Q28479213-DF933F23-CA44-49D8-8896-4AE77CD11F1DQ28484350-81C36B63-F9B3-4492-BEF9-443984D276CAQ28681416-975C8E02-249D-483B-BE85-A5F552B02075Q28748972-B662C1D7-8098-4934-A4B1-302BCE66C126Q30983976-561CA7AC-024F-4DCB-8219-5ED3E376424EQ33527574-7051CCC1-B7A7-43AA-8D89-399BC9FF7DBCQ33537360-F41D40CD-DC0E-451D-B475-6CFEFD20BAFDQ33577945-7AD847CF-A2D3-4EA4-BD47-AE54424E80EDQ33877264-0830177F-7AAC-4877-88A9-54DAF6086B93Q33892834-B575AC97-0D78-4479-9B96-9E00DC318DAAQ33945463-8405DE95-FA96-4734-A6F0-EC19A4022DE0Q33977784-A91E6F5E-90DB-4013-8D8B-92FEE882B3B7Q33988931-A559D4B3-7358-4BEB-AA84-7C2819233E09Q34150129-29F22F15-833B-43DC-BAD9-17E4A5526DB1Q34309550-4CFD0AA6-FE65-42B1-924C-0ABB778D231CQ34321144-5463D161-52B2-4613-888F-81494FF1D416Q34596678-A1D88EBF-FED9-4541-817B-BB185BB0CA30Q34844912-F7CEDF45-C3E6-4B5E-9DF3-F99B34105D71Q35055415-9E795C0E-274E-45ED-A156-FDF6DB51E965Q35385211-7AF7934C-87C8-47D9-8D88-281DC97AB24AQ35455175-E66DF21C-77C3-492D-8B78-0EAEA4632243Q35626884-5F147D32-2D1C-4CF9-B015-6B5180583E79Q35677164-13330FA4-ED8E-4806-B3C2-4357AAD0DBFCQ36242433-4DB6CDB2-B969-4463-B1A3-EF43DFEEB130Q36364219-95147AA8-7DEF-44FD-99CB-47297ADE9D16Q36551331-48BA1AAF-4382-4E8D-8EF9-E0821A649543Q36554155-CA4CE9C7-54B3-4A6C-9963-C83EE4B44027Q36635661-F10A422C-185A-47C7-AABD-6B4E08DAAA81Q37064306-D2F2B3BB-71FD-4D2B-9693-26DAF3F65A1AQ37119288-E273130D-359B-44CA-A4DA-9A509506D68FQ37203764-D1D4E318-D104-4C6B-87E8-A2A9AFF4E3B3Q37379658-D5291B79-F67E-487F-AA06-50ED9A700AF7Q37433712-E22818E4-2D51-4C41-87B8-D9401D5492A4
P2860
Antimicrobial drug resistance of Salmonella enterica serovar typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolones.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Antimicrobial drug resistance ...... ility to the fluoroquinolones.
@ast
Antimicrobial drug resistance ...... ility to the fluoroquinolones.
@en
Antimicrobial drug resistance ...... ility to the fluoroquinolones.
@nl
type
label
Antimicrobial drug resistance ...... ility to the fluoroquinolones.
@ast
Antimicrobial drug resistance ...... ility to the fluoroquinolones.
@en
Antimicrobial drug resistance ...... ility to the fluoroquinolones.
@nl
prefLabel
Antimicrobial drug resistance ...... ility to the fluoroquinolones.
@ast
Antimicrobial drug resistance ...... ility to the fluoroquinolones.
@en
Antimicrobial drug resistance ...... ility to the fluoroquinolones.
@nl
P2093
P2860
P50
P356
P1476
Antimicrobial drug resistance ...... ility to the fluoroquinolones.
@en
P2093
Aliya Naheed
Amit Arjyal
Anne Laure Page
Baiqing Dong
Camilo J Acosta
Christopher M Parry
Claudia M Galindo
Dang Duc Anh
Do Gia Canh
Gordon Dougan
P2860
P304
P356
10.1128/AAC.00294-07
P407
P50
P577
2007-10-01T00:00:00Z